Sandeep V. More
Waegwan, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Emerging preclinical pharmacological targets for Parkinson's disease.
Journal: Oncotarget
Published: October 08, 2015
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Journal: Acta pharmacologica Sinica
Published: September 23, 2015
Colloidal soft nanocarrier for transdermal delivery of dopamine agonist: ex vivo and in vivo evaluation.
Journal: Journal of biomedical nanotechnology
Published: May 23, 2015
α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Journal: Neuropharmacology
Published: January 03, 2015
Anti-neuroinflammatory effects of DPTP, a novel synthetic clovamide derivative in in vitro and in vivo model of neuroinflammation.
Journal: Brain research bulletin
Published: November 06, 2014
EOP, a newly synthesized ethyl pyruvate derivative, attenuates the production of inflammatory mediators via p38, ERK and NF-κB pathways in lipopolysaccharide-activated BV-2 microglial cells.
Journal: Molecules (Basel, Switzerland)
Published: October 10, 2014
β-Asarone (cis-2,4,5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-κB signaling and the JNK pathway in LPS activated BV-2 microglia cells.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: March 17, 2014
Natural product-derived pharmacological modulators of Nrf2/ARE pathway for chronic diseases.
Journal: Natural product reports
Published: December 03, 2013
Traditional Korean East Asian medicines and herbal formulations for cognitive impairment.
Journal: Molecules (Basel, Switzerland)
Published: September 09, 2013
Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: June 06, 2013
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.
Journal: Mediators of inflammation
Published: February 08, 2013
Last Updated: 09/26/2026